Although our study cannot provide conclusive evidence about the long term effects of low-dose dexamethasone after the first four weeks of life in premature neonates with BPD, it still suggests that there may be a relationship between NSE levels and neurodevelopmental outcome. This evidence concerns the gene ENO2 and bronchopulmonary dysplasia.